chr3-111884710-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001134438.2(PHLDB2):c.633G>A(p.Met211Ile) variant causes a missense change. The variant allele was found at a frequency of 0.0000533 in 1,614,126 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.00012 ( 0 hom., cov: 32)
Exomes 𝑓: 0.000047 ( 0 hom. )
Consequence
PHLDB2
NM_001134438.2 missense
NM_001134438.2 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 3.74
Genes affected
PHLDB2 (HGNC:29573): (pleckstrin homology like domain family B member 2) Enables cadherin binding activity. Involved in several processes, including negative regulation of focal adhesion assembly; regulation of cytoskeleton organization; and regulation of embryonic development. Located in several cellular components, including basal cortex; cell leading edge; and intermediate filament cytoskeleton. Colocalizes with focal adhesion. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -2 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.036693692).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PHLDB2 | NM_001134438.2 | c.633G>A | p.Met211Ile | missense_variant | 2/18 | ENST00000431670.7 | NP_001127910.1 | |
PHLDB2 | NM_001134439.2 | c.633G>A | p.Met211Ile | missense_variant | 2/18 | NP_001127911.1 | ||
PHLDB2 | NM_001134437.2 | c.714G>A | p.Met238Ile | missense_variant | 3/18 | NP_001127909.1 | ||
PHLDB2 | NM_145753.2 | c.633G>A | p.Met211Ile | missense_variant | 2/17 | NP_665696.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PHLDB2 | ENST00000431670.7 | c.633G>A | p.Met211Ile | missense_variant | 2/18 | 1 | NM_001134438.2 | ENSP00000405405.2 |
Frequencies
GnomAD3 genomes AF: 0.000118 AC: 18AN: 152128Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
18
AN:
152128
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000518 AC: 13AN: 250808Hom.: 0 AF XY: 0.0000369 AC XY: 5AN XY: 135530
GnomAD3 exomes
AF:
AC:
13
AN:
250808
Hom.:
AF XY:
AC XY:
5
AN XY:
135530
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000465 AC: 68AN: 1461880Hom.: 0 Cov.: 33 AF XY: 0.0000413 AC XY: 30AN XY: 727238
GnomAD4 exome
AF:
AC:
68
AN:
1461880
Hom.:
Cov.:
33
AF XY:
AC XY:
30
AN XY:
727238
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000118 AC: 18AN: 152246Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74430
GnomAD4 genome
AF:
AC:
18
AN:
152246
Hom.:
Cov.:
32
AF XY:
AC XY:
12
AN XY:
74430
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
2
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 25, 2022 | The c.633G>A (p.M211I) alteration is located in exon 2 (coding exon 1) of the PHLDB2 gene. This alteration results from a G to A substitution at nucleotide position 633, causing the methionine (M) at amino acid position 211 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T;T;.;T;T;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;.;T;T;T;T;.
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
.;M;M;.;.;.;M;M
PrimateAI
Benign
T
PROVEAN
Benign
N;N;N;N;N;N;N;N
REVEL
Benign
Sift
Benign
T;T;T;T;T;T;T;T
Sift4G
Benign
T;T;T;T;T;T;T;T
Polyphen
B;B;B;.;B;B;B;B
Vest4
MutPred
0.16
.;Gain of glycosylation at S212 (P = 0.0033);Gain of glycosylation at S212 (P = 0.0033);Gain of glycosylation at S212 (P = 0.0033);Gain of glycosylation at S212 (P = 0.0033);Gain of glycosylation at S212 (P = 0.0033);Gain of glycosylation at S212 (P = 0.0033);Gain of glycosylation at S212 (P = 0.0033);
MVP
MPC
0.10
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at